[HTML][HTML] Prostate cancer, online health information and communication technology–bibliometric analysis of field with research frontiers.
SR Jackson, S Chambers, S Leslie, MI Patel - Patient Education and …, 2023 - Elsevier
Objectives The purpose of this study is to conduct the first bibliometric analysis which
examines eHealth communication technologies in prostate cancer care, and the utilization of …
examines eHealth communication technologies in prostate cancer care, and the utilization of …
Social and demographic patterns of health-related Internet use among adults in the United States: a secondary data analysis of the health information national trends …
R Calixte, A Rivera, O Oridota, W Beauchamp… - International Journal of …, 2020 - mdpi.com
National surveys of US adults have observed significant increases in health-related internet
use (HRIU), but there are documented disparities. The study aims to identify social and …
use (HRIU), but there are documented disparities. The study aims to identify social and …
[HTML][HTML] The immediate, intermediate, and long-term effectiveness of audiovisuals for providing pre-treatment information to patients with cancer: A systematic review
SLL Duimel, RJJH van Son, AJ Linn… - Patient Education and …, 2025 - Elsevier
Objective To assess the effectiveness of audiovisuals in providing pre-treatment information
to patients with cancer. Following the Six Function Model of Medical Communication, we …
to patients with cancer. Following the Six Function Model of Medical Communication, we …
[HTML][HTML] Evaluating the efficacy of ChatGPT as a patient education tool in prostate cancer: multimetric assessment
D Gibson, S Jackson, R Shanmugasundaram… - Journal of Medical …, 2024 - jmir.org
Background Artificial intelligence (AI) chatbots, such as ChatGPT, have made significant
progress. These chatbots, particularly popular among health care professionals and …
progress. These chatbots, particularly popular among health care professionals and …
Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study
VLMN Soomers, O Husson, IME Desar… - Cancer, 2020 - Wiley Online Library
Background Patients diagnosed with sarcoma are hypothesized to experience a prolonged
route to a cancer diagnosis. This route, the total interval, can be divided into a patient …
route to a cancer diagnosis. This route, the total interval, can be divided into a patient …
Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?
Background The increased availability of patient reported outcome data makes it feasible to
provide patients tailored risk information of cancer treatment side effects. However, it is …
provide patients tailored risk information of cancer treatment side effects. However, it is …
[HTML][HTML] Exploring cancer survivor needs and preferences for communicating personalized cancer statistics from registry data: qualitative multimethod study
Background: Disclosure of cancer statistics (eg, survival or incidence rates) based on a
representative group of patients can help increase cancer survivors' understanding of their …
representative group of patients can help increase cancer survivors' understanding of their …
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical …
R Berardi, A Parisi, M Maruzzo, M Bellani… - Supportive Care in …, 2024 - Springer
Aim To identify barriers between health and communication in oncology in order to promote
the best possible practice. The areas of communication to be focused on are communication …
the best possible practice. The areas of communication to be focused on are communication …
Communication in decision aids for stage I–III colorectal cancer patients: a systematic review
Objectives To assess the communicative quality of colorectal cancer patient decision aids
(DAs) about treatment options, the current systematic review was conducted. Design …
(DAs) about treatment options, the current systematic review was conducted. Design …
Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer
A Boucenna, K Boudaoud, A Hireche… - Egyptian Journal of …, 2022 - Springer
Background Tamoxifen, a selective estrogen receptor modulator, is indicated for breast
cancer developed in response to estrogen. Findings In the current study we explored the …
cancer developed in response to estrogen. Findings In the current study we explored the …